Yi-jou Tai

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Tamoxifen Use and Risk of Uterine Diseases in Young Women With Breast Cancer.

Tamoxifen Use and Risk of Uterine Diseases in Young Women With Breast Cancer.

Journal: Obstetrics and gynecology

Published: July 16, 2026

Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classification.

Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classification.

Journal: Gynecologic oncology

Published: December 17, 2025

A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancer.

A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancer.

Journal: Journal of ovarian research

Published: December 10, 2025

Uncoupling anatomical barriers from radiotherapy toxicity: a two-part hurdle analysis of sexual function in gynecologic cancer.

Uncoupling anatomical barriers from radiotherapy toxicity: a two-part hurdle analysis of sexual function in gynecologic cancer.

Journal: The journal of sexual medicine

Published: December 09, 2025

Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancer.

Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancer.

Journal: Briefings in bioinformatics

Published: October 02, 2025

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 18, 2025

Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors.

Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors.

Journal: International journal of molecular sciences

Published: May 31, 2025

Risk factors of recurrent cervical intraepithelial neoplasm 2/3 after primary excisional conization/LEEP treatments: A follow-up nationwide cohort study.

Risk factors of recurrent cervical intraepithelial neoplasm 2/3 after primary excisional conization/LEEP treatments: A follow-up nationwide cohort study.

Journal: European journal of obstetrics & gynecology and reproductive biology: X

Published: April 02, 2025

Association of homologous recombination repair gene mutation with clinical prognosis in histological subtypes of epithelial ovarian cancer patients.

Association of homologous recombination repair gene mutation with clinical prognosis in histological subtypes of epithelial ovarian cancer patients.

Journal: Journal of gynecologic oncology

Published: March 02, 2025

A Case of Uterine Adenosarcoma and Colonic Endometriosis Masquerading as Inflammatory Bowel Disease.

A Case of Uterine Adenosarcoma and Colonic Endometriosis Masquerading as Inflammatory Bowel Disease.

Journal: Digestive diseases and sciences

Published: February 17, 2025

Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study.

Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study.

Journal: Gynecologic oncology reports

Published: January 29, 2025

Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.

Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 16, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026